417 related articles for article (PubMed ID: 17920367)
1. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S; Parkar S; Grossman E; Messerli FH
Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
[TBL] [Abstract][Full Text] [Related]
2. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
[TBL] [Abstract][Full Text] [Related]
4. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
5. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
[TBL] [Abstract][Full Text] [Related]
6. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects.
Mykkänen L; Kuusisto J; Pyörälä K; Laakso M; Haffner SM
J Hypertens; 1994 Dec; 12(12):1425-32. PubMed ID: 7706704
[TBL] [Abstract][Full Text] [Related]
8. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
[TBL] [Abstract][Full Text] [Related]
10. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ;
Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868
[TBL] [Abstract][Full Text] [Related]
11. Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Aksnes TA; Kjeldsen SE; Rostrup M; Störset O; Hua TA; Julius S
J Hum Hypertens; 2008 Aug; 22(8):520-7. PubMed ID: 18509347
[TBL] [Abstract][Full Text] [Related]
12. Risk of new-onset diabetes mellitus in patients with hypertension treated with beta blockers.
Ram CV
Am J Cardiol; 2008 Jul; 102(2):242-4; author reply 244-8. PubMed ID: 18602529
[No Abstract] [Full Text] [Related]
13. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic antagonists in hypertension: a review of the evidence.
Warmack TS; Estes MA; Heldenbrand S; Franks AM
Ann Pharmacother; 2009 Dec; 43(12):2031-43. PubMed ID: 19934392
[TBL] [Abstract][Full Text] [Related]
15. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.
Kuyper LM; Khan NA
Can J Cardiol; 2014 May; 30(5 Suppl):S47-53. PubMed ID: 24750981
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
Andraws R; Brown DL
Am J Cardiol; 2007 Apr; 99(7):1006-12. PubMed ID: 17398202
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular protection using beta-blockers: a critical review of the evidence.
Bangalore S; Messerli FH; Kostis JB; Pepine CJ
J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
20. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
